Skip to main content
NCBI home page
Sarcoma logoLink to Sarcoma
. 2001 Sep;5(3):157–184. doi: 10.1080/135771401200XXXXX

Soft Tissue and Bone Sarcoma Group, 25th Anniversary Meeting on Sarcomas, April 5–7, 2001, Aarhus, Denmark

John Gibbs 1,✉
PMCID: PMC2408367  PMID: 18521443

Full Text

The Full Text of this article is available as a PDF (423.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997 Dec 6;350(9092):1647–1654. [PubMed] [Google Scholar]
  2. Alvegård T. A., Sigurdsson H., Mouridsen H., Solheim O., Unsgaard B., Ringborg U., Dahl O., Nordentoft A. M., Blomqvist C., Rydholm A. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol. 1989 Oct;7(10):1504–1513. doi: 10.1200/JCO.1989.7.10.1504. [DOI] [PubMed] [Google Scholar]
  3. Bramwell V., Rouesse J., Steward W., Santoro A., Schraffordt-Koops H., Buesa J., Ruka W., Priario J., Wagener T., Burgers M. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994 Jun;12(6):1137–1149. doi: 10.1200/JCO.1994.12.6.1137. [DOI] [PubMed] [Google Scholar]
  4. Edmonson J. H., Fleming T. R., Ivins J. C., Burgert E. O., Jr, Soule E. H., O'Connell M. J., Sim F. H., Ahmann D. L. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol. 1984 Dec;2(12):1390–1396. doi: 10.1200/JCO.1984.2.12.1390. [DOI] [PubMed] [Google Scholar]
  5. Eggermont A. M., Schraffordt Koops H., Liénard D., Kroon B. B., van Geel A. N., Hoekstra H. J., Lejeune F. J. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol. 1996 Oct;14(10):2653–2665. doi: 10.1200/JCO.1996.14.10.2653. [DOI] [PubMed] [Google Scholar]
  6. Folpe A. L., Lyles R. H., Sprouse J. T., Conrad E. U., 3rd, Eary J. F. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000 Apr;6(4):1279–1287. [PubMed] [Google Scholar]
  7. Gherlinzoni F., Bacci G., Picci P., Capanna R., Calderoni P., Lorenzi E. G., Bernini M., Emiliani E., Barbieri E., Normand A. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol. 1986 Apr;4(4):552–558. doi: 10.1200/JCO.1986.4.4.552. [DOI] [PubMed] [Google Scholar]
  8. Glenn J., Kinsella T., Glatstein E., Tepper J., Baker A., Sugarbaker P., Sindelar W., Roth J., Brennan M., Costa J. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer. 1985 Mar 15;55(6):1206–1214. doi: 10.1002/1097-0142(19850315)55:6<1206::aid-cncr2820550612>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  9. Glenn J., Sindelar W. F., Kinsella T., Glatstein E., Tepper J., Costa J., Baker A., Sugarbaker P., Brennan M. F., Seipp C. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985 Mar;97(3):316–325. [PubMed] [Google Scholar]
  10. Klicks R. J., Vrouenraets B. C., Nieweg O. E., Kroon B. B. Vascular complications of isolated limb perfusion. Eur J Surg Oncol. 1998 Aug;24(4):288–291. doi: 10.1016/s0748-7983(98)80008-5. [DOI] [PubMed] [Google Scholar]
  11. Le Cesne A., Judson I., Crowther D., Rodenhuis S., Keizer H. J., Van Hoesel Q., Blay J. Y., Frisch J., Van Glabbeke M., Hermans C. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 2000 Jul;18(14):2676–2684. doi: 10.1200/JCO.2000.18.14.2676. [DOI] [PubMed] [Google Scholar]
  12. Lejeune F. J., Pujol N., Liénard D., Mosimann F., Raffoul W., Genton A., Guillou L., Landry M., Chassot P. G., Chiolero R. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Eur J Surg Oncol. 2000 Nov;26(7):669–678. doi: 10.1053/ejso.2000.0979. [DOI] [PubMed] [Google Scholar]
  13. Lejeune F. J., Rüegg C., Liénard D. Clinical applications of TNF-alpha in cancer. Curr Opin Immunol. 1998 Oct;10(5):573–580. doi: 10.1016/s0952-7915(98)80226-4. [DOI] [PubMed] [Google Scholar]
  14. Lienard D., Ewalenko P., Delmotte J. J., Renard N., Lejeune F. J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992 Jan;10(1):52–60. doi: 10.1200/JCO.1992.10.1.52. [DOI] [PubMed] [Google Scholar]
  15. Lucas J. D., O'Doherty M. J., Wong J. C., Bingham J. B., McKee P. H., Fletcher C. D., Smith M. A. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br. 1998 May;80(3):441–447. doi: 10.1302/0301-620x.80b3.8232. [DOI] [PubMed] [Google Scholar]
  16. Olieman A. F., Pras E., van Ginkel R. J., Molenaar W. M., Schraffordt Koops H., Hoekstra H. J. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):807–814. doi: 10.1016/s0360-3016(97)00923-1. [DOI] [PubMed] [Google Scholar]
  17. Omura G. A., Blessing J. A., Major F., Lifshitz S., Ehrlich C. E., Mangan C., Beecham J., Park R., Silverberg S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol. 1985 Sep;3(9):1240–1245. doi: 10.1200/JCO.1985.3.9.1240. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Young R., Baker A., Brennan M. F., Demoss E. V., Seipp C., Sindelar W. F. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983 Aug 1;52(3):424–434. doi: 10.1002/1097-0142(19830801)52:3<424::aid-cncr2820520307>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  19. Schulte M., Brecht-Krauss D., Werner M., Hartwig E., Sarkar M. R., Keppler P., Kotzerke J., Guhlmann A., Delling G., Reske S. N. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med. 1999 Oct;40(10):1637–1643. [PubMed] [Google Scholar]
  20. Van Glabbeke M., van Oosterom A. T., Oosterhuis J. W., Mouridsen H., Crowther D., Somers R., Verweij J., Santoro A., Buesa J., Tursz T. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 1999 Jan;17(1):150–157. doi: 10.1200/JCO.1999.17.1.150. [DOI] [PubMed] [Google Scholar]
  21. Vrouenraets B. C., Keus R. B., Nieweg O. E., Kroon B. B. Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors. J Surg Oncol. 1997 Jun;65(2):88–94. doi: 10.1002/(sici)1096-9098(199706)65:2<88::aid-jso4>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES